Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

BMRN Insider Trading (BioMarin Pharmaceutical)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.75%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $12,530,005.35

BioMarin Pharmaceutical Insider Trading History Chart

BioMarin Pharmaceutical Share Price & Price History

^$82.86

▼ -1.06 (-1.26%)

As of 06/30/2022 04:52 PM ET

Days: 30 | 90 | 365

Former Lawyer Went From $50K To $5.3M Trading Options

From Investing Daily | Ad

Slaving away for 70 hrs a week as a lawyer in Chicago, I was miserable.

I ran into guys who worked the trading floor at the local exchange. I began trading the same way they did. I started out with $50K (much more than I needed, actually).

I grew my $50K into $5.3M

I'll show you how I did it here.

BioMarin Pharmaceutical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/26/2022	Jeffrey Robert Ajer	EVP	Sell	1,308	$78.94	$103,253.52	54,109
5/5/2022	Jean Jacques Bienaime	CEO	Sell	10,000	$84.14	$841,400.00	335,324
5/4/2022	Brian R. Mueller	CFO	Sell	11,800	$84.50	$997,100.00	38,639
5/2/2022	George Eric Davis	EVP	Sell	15,347	$80.38	$1,233,591.86	66,339
5/2/2022	Richard A. Meier	Director	Sell	3,878	$82.09	$318,345.02	104,014
4/28/2022	Jean Jacques Bienaime	CEO	Sell	20,000	$83.79	$1,675,800.00	334,983
4/18/2022	Jean Jacques Bienaime	CEO	Sell	20,000	$81.91	$1,638,200.00	334,983
4/14/2022	Jean Jacques Bienaime	CEO	Sell	10,000	$83.66	$836,600.00	334,983
4/14/2022	V. Bryan Lawlis	Director	Sell	4,250	$83.66	$355,555.00	23,970
4/13/2022	Jeffrey Robert Ajer	EVP	Sell	1,180	$82.47	$97,314.60	55,077
3/29/2022	Jeffrey Robert Ajer	EVP	Sell	1,618	$79.43	$128,517.74
3/23/2022	Jeffrey Robert Ajer	EVP	Sell	6,129	$81.78	$501,229.62
3/21/2022	George Eric Davis	EVP	Sell	6,129	$81.29	$498,226.41
3/10/2022	Jean Jacques Bienaime	CEO	Sell	15,000	$77.57	$1,163,550.00
2/28/2022	Dennis Slamon	Director	Sell	6,396	$78.33	$500,998.68
1/14/2022	V. Bryan Lawlis	Director	Sell	4,250	$87.61	$372,342.50
1/13/2022	Jean Jacques Bienaime	CEO	Sell	5,000	$87.86	$439,300.00
12/15/2021	Jean Jacques Bienaime	CEO	Sell	6,000	$82.71	$496,260.00
12/1/2021	Jean Jacques Bienaime	CEO	Sell	1,500	$87.22	$130,830.00
10/26/2021	Jeffrey Robert Ajer	EVP	Sell	2,739	$73.60	$201,590.40
5/10/2021	Jean Jacques Bienaime	CEO	Sell	8,513	$77.29	$657,969.77	312,352
5/7/2021	Brian R. Mueller	CFO	Sell	6,709	$79.50	$533,365.50	31,357
5/7/2021	Jean Jacques Bienaime	CEO	Sell	25,000	$78.12	$1,953,000.00	303,839
5/6/2021	Richard A. Meier	Director	Sell	5,068	$78.38	$397,229.84	99,340
5/3/2021	George Eric Davis	EVP	Sell	4,673	$78.30	$365,895.90	68,781
4/23/2021	Jean Jacques Bienaime	CEO	Sell	10,000	$79.34	$793,400.00	312,498
4/19/2021	George Eric Davis	EVP	Sell	2,709	$79.58	$215,582.22	71,149
4/8/2021	Jeffrey Robert Ajer	EVP	Sell	1,537	$78.81	$121,130.97	58,250
4/1/2021	Brian R. Mueller	CFO	Sell	5,692	$76.30	$434,299.60	31,016
3/24/2021	Jeffrey Robert Ajer	EVP	Sell	1,181	$76.30	$90,110.30	61,439
3/18/2021	Jeffrey Robert Ajer	EVP	Sell	1,308	$77.99	$102,010.92	64,133
3/11/2021	Jean Jacques Bienaime	CEO	Sell	7,000	$77.68	$543,760.00	295,652
3/5/2021	Michael G. Grey	Director	Sell	5,000	$76.28	$381,400.00	47,840
2/19/2021	Jean Jacques Bienaime	CEO	Sell	7,000	$83.58	$585,060.00	302,552
2/17/2021	Jean Jacques Bienaime	CEO	Sell	8,000	$84.54	$676,320.00	303,552
1/29/2021	Jean Jacques Bienaime	CEO	Sell	8,334	$82.67	$688,971.78	303,885
1/27/2021	Jean Jacques Bienaime	CEO	Sell	8,333	$85.49	$712,388.17	303,885
12/28/2020	Jean Jacques Bienaime	CEO	Sell	1,500	$88.77	$133,155.00	297,052
10/14/2020	Jeffrey Robert Ajer	EVP	Sell	2,121	$79.91	$169,489.11	61,281
8/31/2020	David E.I. Pyott	Director	Buy	12,800	$78.26	$1,001,728.00	29,840
8/3/2020	Michael G. Grey	Director	Sell	2,500	$120.35	$300,875.00	45,340
7/20/2020	Henry J. Fuchs	Insider	Sell	126,389	$130.00	$16,430,570.00	104,245
7/13/2020	Henry J. Fuchs	Insider	Sell	23,011	$130.00	$2,991,430.00	102,995
6/26/2020	Willard H. Dere	Director	Sell	4,430	$123.61	$547,592.30	13,290
6/19/2020	Jeffrey Robert Ajer	EVP	Sell	15,000	$124.00	$1,860,000.00	63,402
6/5/2020	V. Bryan Lawlis	Director	Sell	4,430	$107.46	$476,047.80	18,850
5/8/2020	Jean Jacques Bienaime	CEO	Sell	20,000	$91.72	$1,834,400.00	318,552
5/4/2020	Jean Jacques Bienaime	CEO	Sell	5,000	$88.00	$440,000.00	298,552
5/1/2020	George Eric Davis	EVP	Sell	12,504	$89.38	$1,117,607.52	78,181
5/1/2020	Jean Jacques Bienaime	CEO	Sell	4,000	$89.38	$357,520.00	298,552
4/28/2020	Jean Jacques Bienaime	CEO	Sell	20,000	$97.58	$1,951,600.00	318,213
4/24/2020	Henry J. Fuchs	Insider	Sell	20,000	$95.88	$1,917,600.00	109,014
4/20/2020	Henry J. Fuchs	Insider	Sell	17,213	$90.00	$1,549,170.00	122,656
4/9/2020	Jean Jacques Bienaime	CEO	Sell	10,000	$79.06	$790,600.00	308,213
4/8/2020	Jeffrey Robert Ajer	EVP	Sell	2,407	$79.98	$192,511.86	63,064
4/1/2020	Jeffrey Robert Ajer	EVP	Sell	1,537	$82.00	$126,034.00	65,471
3/24/2020	Jeffrey Robert Ajer	EVP	Sell	2,041	$74.36	$151,768.76	68,626
3/17/2020	V. Bryan Lawlis	Director	Sell	3,750	$75.39	$282,712.50	18,980
3/9/2020	Jean Jacques Bienaime	CEO	Sell	10,000	$89.52	$895,200.00	296,443
1/14/2020	Jean Jacques Bienaime	CEO	Sell	8,000	$87.95	$703,600.00	335,530
1/7/2020	Jean Jacques Bienaime	CEO	Sell	3,000	$84.46	$253,380.00	330,530
12/27/2019	Jean Jacques Bienaime	CEO	Sell	5,000	$86.16	$430,800.00
12/17/2019	V. Bryan Lawlis	Director	Sell	3,750	$83.36	$312,600.00	27,340
11/26/2019	George Eric Davis	EVP	Sell	3,190	$79.66	$254,115.40	68,709
11/22/2019	Jean Jacques Bienaime	CEO	Sell	10,000	$77.60	$776,000.00	327,070
10/25/2019	Jean Jacques Bienaime	CEO	Sell	5,000	$69.55	$347,750.00	332,520
9/17/2019	V. Bryan Lawlis	Director	Sell	3,750	$74.47	$279,262.50	27,340

What Investors Don't Know: Communist China Could Profit Billions From The World "Going Green."

From Investing Trends | Ad

Who controls 80% of the works lithium supply (the most important metal for building EV batteries)? China! And if you're outraged by that fact, then you'll love hearing how this western company is fighting back…

See How This Lithium Play Could Explode

SEC Filings (Institutional Ownership Changes) for BioMarin Pharmaceutical (NASDAQ:BMRN)

95.45% of BioMarin Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioMarin Pharmaceutical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/8/2022	American Trust	2,748	$0.21M	0.0%	-5.2%	0.001%
6/7/2022	Teachers Retirement System of The State of Kentucky	146,771	$11.32M	0.1%	-12.0%	0.079%
6/2/2022	Mirae Asset Global Investments Co. Ltd.	139,070	$10.72M	0.0%	-14.8%	0.075%
5/27/2022	Walleye Capital LLC	115,649	$8.92M	0.2%	+906.1%	0.063%
5/26/2022	Rice Hall James & Associates LLC	59,470	$4.59M	0.2%	-3.3%	0.032%
5/23/2022	Neuberger Berman Group LLC	27,723	$2.14M	0.0%	-15.2%	0.015%
5/20/2022	International Biotechnology Trust PLC	79,656	$0.24M	0.1%	-24.2%	0.043%
5/20/2022	The Manufacturers Life Insurance Company	21,097	$1.64M	0.0%	+538.1%	0.011%
5/20/2022	Toroso Investments LLC	4,792	$0.37M	0.0%	+11.0%	0.003%
5/19/2022	Capital Research Global Investors	9,387,956	$723.83M	0.2%	-25.9%	5.075%
5/18/2022	Gabelli Funds LLC	17,620	$1.36M	0.0%	-12.9%	0.010%
5/18/2022	Gamco Investors INC. ET AL	4,062	$0.31M	0.0%	-14.8%	0.002%
5/17/2022	Worldquant Millennium Advisors LLC	24,827	$1.91M	0.0%	-58.5%	0.013%
5/17/2022	Walleye Capital LLC	115,649	$8.92M	0.2%	+906.1%	0.063%
5/17/2022	Weiss Multi Strategy Advisers LLC	13,943	$1.08M	0.0%	-28.1%	0.008%
5/17/2022	Virtu Financial LLC	12,122	$0.94M	0.1%	N/A	0.007%
5/17/2022	Advisors Asset Management Inc.	12,642	$0.98M	0.0%	-5.6%	0.007%
5/17/2022	Meiji Yasuda Asset Management Co Ltd.	13,731	$1.06M	0.1%	-1.7%	0.007%
5/17/2022	Beacon Pointe Advisors LLC	16,417	$1.27M	0.0%	+10.0%	0.009%
5/17/2022	Point72 Hong Kong Ltd	7,836	$0.60M	0.0%	+54.6%	0.004%
5/17/2022	Polar Capital Holdings Plc	500,000	$38.55M	0.2%	+300.0%	0.270%
5/17/2022	Quantbot Technologies LP	3,792	$0.29M	0.0%	+48.9%	0.002%
5/17/2022	Rock Springs Capital Management LP	264,500	$20.39M	0.5%	+0.2%	0.143%
5/17/2022	Dynamic Technology Lab Private Ltd	16,890	$1.30M	0.2%	N/A	0.009%
5/17/2022	Eaton Vance Management	80,806	$6.23M	0.0%	+349.6%	0.044%
5/17/2022	Ensign Peak Advisors Inc	45,390	$3.50M	0.0%	-14.7%	0.025%
5/17/2022	Eqis Capital Management Inc.	6,686	$0.52M	0.0%	-7.1%	0.004%
5/17/2022	First Republic Investment Management Inc.	13,495	$1.04M	0.0%	+20.6%	0.007%
5/17/2022	Guggenheim Capital LLC	58,846	$4.54M	0.0%	-10.8%	0.032%
5/17/2022	1832 Asset Management L.P.	500,382	$38.07M	0.1%	+28.3%	0.270%
5/16/2022	California State Teachers Retirement System	303,867	$23.43M	0.0%	-5.7%	0.164%
5/16/2022	Goldman Sachs Group Inc.	708,618	$54.63M	0.0%	-2.5%	0.383%
5/16/2022	PDT Partners LLC	6,888	$0.53M	0.0%	N/A	0.004%
5/16/2022	Viking Global Investors LP	3,752,393	$289.31M	1.2%	+30.7%	2.028%
5/16/2022	Palo Alto Investors LP	2,139,614	$164.96M	12.8%	-3.3%	1.157%
5/16/2022	Captrust Financial Advisors	3,274	$0.25M	0.0%	-12.4%	0.002%
5/16/2022	Allstate Corp	10,097	$0.78M	0.0%	N/A	0.005%
5/16/2022	Brinker Capital Investments LLC	16,544	$1.28M	0.0%	+40.8%	0.009%
5/16/2022	Echo Street Capital Management LLC	14,612	$1.13M	0.0%	N/A	0.008%
5/16/2022	United Capital Financial Advisers LLC	14,610	$1.13M	0.0%	-1.6%	0.008%
5/16/2022	Vident Investment Advisory LLC	10,307	$0.79M	0.0%	-4.2%	0.006%
5/16/2022	Atria Wealth Solutions Inc.	8,112	$0.63M	0.0%	N/A	0.004%
5/16/2022	Graham Capital Management L.P.	17,477	$1.35M	0.0%	+410.9%	0.009%
5/16/2022	Hsbc Holdings PLC	84,275	$6.53M	0.0%	+70.0%	0.046%
5/13/2022	Rhenman & Partners Asset Management AB	220,000	$16.96M	1.7%	-17.0%	0.119%
5/13/2022	Renaissance Technologies LLC	491,171	$37.87M	0.0%	-24.6%	0.266%
5/13/2022	Nan Fung Group Holdings Ltd	6,115	$0.47M	0.2%	-18.0%	0.003%
5/13/2022	Bellevue Group AG	74,600	$5.75M	0.1%	+4.5%	0.040%
5/13/2022	Ontario Teachers Pension Plan Board	15,309	$1.18M	0.0%	N/A	0.008%
5/13/2022	Northern Trust Corp	1,326,454	$102.27M	0.0%	-2.7%	0.717%
5/13/2022	Industrial Alliance Investment Management Inc.	50,480	$3.90M	0.1%	N/A	0.027%
5/13/2022	Charles Schwab Investment Management Inc.	1,128,030	$86.97M	0.0%	+2.5%	0.610%
5/13/2022	Edgestream Partners L.P.	16,701	$1.29M	0.1%	N/A	0.009%
5/13/2022	Utah Retirement Systems	32,578	$2.51M	0.0%	-1.5%	0.018%
5/13/2022	Mariner LLC	24,060	$1.86M	0.0%	+21.8%	0.013%
5/13/2022	Gabelli Funds LLC	17,620	$1.36M	0.0%	-12.9%	0.010%
5/13/2022	Gamco Investors INC. ET AL	4,062	$0.31M	0.0%	-14.8%	0.002%
5/13/2022	Caisse DE Depot ET Placement DU Quebec	31,734	$2.45M	0.0%	+851.8%	0.017%
5/13/2022	First Light Asset Management LLC	93,082	$7.18M	0.6%	-27.2%	0.050%
5/13/2022	Clearbridge Investments LLC	2,109,376	$162.63M	0.1%	-59.9%	1.140%
5/13/2022	Laurel Wealth Advisors Inc.	2,955	$0.23M	0.0%	N/A	0.002%
5/13/2022	qPULA Trading Management LP	5,268	$0.41M	0.5%	N/A	0.003%
5/13/2022	Parkwood LLC	3,505	$0.27M	0.0%	-6.0%	0.002%
5/13/2022	First Trust Advisors LP	603,648	$46.54M	0.0%	-46.3%	0.326%
5/13/2022	XTX Topco Ltd	7,794	$0.60M	0.3%	+157.8%	0.004%
5/13/2022	Royal London Asset Management Ltd.	64,300	$4.96M	0.0%	+5.9%	0.035%
5/13/2022	Prudential Financial Inc.	87,583	$6.75M	0.0%	+35.6%	0.047%
5/13/2022	Federated Hermes Inc.	3,998	$0.31M	0.0%	-71.5%	0.002%
5/13/2022	USS Investment Management Ltd	63,501	$4.90M	0.0%	+34.7%	0.034%
5/13/2022	Bridgewater Associates LP	19,650	$1.52M	0.0%	+40.5%	0.011%
5/13/2022	Pearl River Capital LLC	19,961	$1.54M	0.4%	N/A	0.011%
5/13/2022	Bridgefront Capital LLC	4,407	$0.34M	0.4%	N/A	0.002%
5/13/2022	American National Insurance Co.	3,425	$0.26M	0.1%	-20.2%	0.002%
5/13/2022	Mackenzie Financial Corp	115,963	$8.94M	0.0%	-3.1%	0.063%
5/13/2022	Zions Bancorporation N.A.	5,030	$0.39M	0.0%	-20.0%	0.003%
5/13/2022	Baird Financial Group Inc.	17,489	$1.35M	0.0%	-3.9%	0.009%
5/13/2022	Vanguard Group Inc.	16,502,243	$1.27B	0.0%	+0.9%	8.921%
5/13/2022	National Pension Service	308,306	$23.77M	0.0%	N/A	0.167%
5/13/2022	Cetera Investment Advisers	5,959	$0.46M	0.0%	-7.9%	0.003%
5/13/2022	Prudential PLC	22,831	$1.76M	0.0%	+14.8%	0.012%
5/13/2022	Canada Pension Plan Investment Board	17,624	$1.36M	0.0%	-65.3%	0.010%
5/13/2022	Aviva PLC	36,033	$2.78M	0.0%	-99.3%	0.019%
5/13/2022	Blair William & Co. IL	41,170	$3.17M	0.0%	+1.4%	0.022%
5/13/2022	Vontobel Holding Ltd.	7,231	$0.56M	0.0%	-13.0%	0.004%
5/13/2022	Dimensional Fund Advisors LP	554,130	$42.73M	0.0%	+0.4%	0.300%
5/12/2022	Synovus Financial Corp	19,582	$1.51M	0.0%	-6.5%	0.011%
5/12/2022	Integral Health Asset Management LLC	80,000	$6.17M	1.6%	+66.7%	0.043%
5/12/2022	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	28,343	$2.19M	0.0%	-11.9%	0.015%
5/12/2022	Westwood Holdings Group Inc.	12,812	$0.99M	0.0%	-10.3%	0.007%
5/12/2022	Great West Life Assurance Co. Can	152,710	$12.47M	0.0%	-2.9%	0.083%
5/12/2022	APG Asset Management N.V.	524,232	$36.33M	0.1%	-0.2%	0.283%
5/12/2022	Freestone Capital Holdings LLC	6,987	$0.54M	0.0%	-20.7%	0.004%
5/12/2022	Rhumbline Advisers	163,386	$12.60M	0.0%	+4.7%	0.088%
5/12/2022	Panagora Asset Management Inc.	10,249	$0.79M	0.0%	-2.0%	0.006%
5/12/2022	MetLife Investment Management LLC	3,647	$0.28M	0.0%	N/A	0.002%
5/12/2022	Martingale Asset Management L P	55,466	$4.28M	0.1%	+36.5%	0.030%
5/12/2022	Aureus Asset Management LLC	6,661	$0.51M	0.0%	N/A	0.004%
5/12/2022	CI Investments Inc.	3,778	$0.29M	0.0%	-9.1%	0.002%
5/12/2022	Acadian Asset Management LLC	431	$32K	0.0%	+395.4%	0.000%
5/12/2022	Bank of Montreal Can	230,924	$18.29M	0.0%	+48.4%	0.125%

Data available starting January 2016

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops valoctocogene roxaparvovec, an adeno associated virus vector, which is in Phase III clinical trial for the treatment of patients with severe hemophilia A; BMN 307, an AAV5 mediated gene therapy, which is in Phase 1/2 clinical trial to normalize blood Phe concentration levels in patients with PKU; and BMN 255 that is in Phase 1/2 clinical trial for treating primary hyperoxaluria. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc., and Asubio Pharma Co., Ltd. The company was incorporated in 1996 and is headquartered in San Rafael, California.

Today's Range

Now: $82.86

$81.85

$83.84

50 Day Range

MA: $78.94

$71.48

$86.85

52 Week Range

Now: $82.86

$70.73

$94.20

Volume

34,569 shs

Average Volume

1,298,221 shs

Market Capitalization

$15.33 billion

P/E Ratio

466.22

Dividend Yield

N/A

Beta

0.42

Who are the company insiders with the largest holdings of BioMarin Pharmaceutical?: BioMarin Pharmaceutical's top insider shareholders include:
Jean Jacques Bienaime (CEO)
Henry J Fuchs (Insider)
Richard A Meier (Director)
George Eric Davis (EVP)
Jeffrey Robert Ajer (EVP)
Michael G Grey (Director)
Brian Mueller (CFO)
David E I Pyott (Director)
V Bryan Lawlis (Director)
Dennis Slamon (Director)
Learn More about top insider investors at BioMarin Pharmaceutical.

47-second trade demo: how to make ANY bear market cough up cash

From Tradesmith | Ad

It's a bloodbath out there. But while most investors sweat bullets wondering what to do… (And where to find ANY safe haven for their money). Trading expert Keith Kaplan has created an "income loop" algorithm …that actually FORCES instant cash out of every trade. Click here to view a live "demo".

>>>